FINRA clears Form 211 for Invech Holdings (OTC: IVHI) OTC quotations
Rhea-AI Filing Summary
Invech Holdings, Inc. reported that on September 8, 2025, FINRA deemed effective a Form 15c2-11 (Form 211) submitted by Glendale Securities, Inc. for the company’s common stock. This effectiveness permits Glendale Securities to resume publishing quotations for Invech’s shares on an over-the-counter quotation platform.
The company states that this step is important for increasing the visibility and liquidity of its common stock in public markets. Invech also notes that it is working with partners to strengthen its market presence and to provide more transparent and timely information to shareholders and the wider investment community.
Positive
- FINRA Form 211 deemed effective, enabling OTC quotations: Glendale Securities, Inc. can resume publishing quotes for Invech Holdings, Inc.’s common stock, which the company describes as a significant step toward increasing market visibility and liquidity.
Negative
- None.
Insights
FINRA Form 211 effectiveness restores OTC quotations, improving potential liquidity and visibility for Invech’s shares.
The effectiveness of the Form 211 for Invech Holdings, Inc. allows Glendale Securities, Inc. to resume publishing quotes for the company’s common stock on an OTC quotation medium. This is a key regulatory step for broker-dealers to make a market in a security under Rule 15c2-11.
Being quoted again can help investors see real-time bid and ask prices, which may support more consistent trading activity. The company highlights that this development is a “significant step” toward better visibility and liquidity, though actual trading levels will depend on market-maker interest and investor demand.
Invech also emphasizes plans to work with partners to expand its market presence and improve disclosure quality. Future SEC and market disclosures will show how actively the stock is quoted and traded following the Form 211 effectiveness and how the company executes on its communication efforts.